Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 140-151

  Andreadou, Ioanna ^a   Bibli, Sofia Iris ^a   Mastromanolis, Emmanuel ^b   Zoga, Anastasia ^b   Efentakis, Panagiotis ^a   Papaioannou, Nikolaos ^c   Farmakis, Dimitrios ^b   Kremastinos, Dimitrios Th ^b   Iliodromitis, Efstathios K ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cardioprotection; ENOS; Perconditioning; Risk; SAFE; STAT5

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANGIOTENSIN II; CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; N(G) NITROARGININE METHYL ESTER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; STAT5 PROTEIN; VALSARTAN; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART PROTECTION; INTRACELLULAR SIGNALING; ISCHEMIA; MALE; NONHUMAN; PERCONDITIONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION; ANIMAL; INTRACELLULAR FLUID; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RABBIT; SIGNAL TRANSDUCTION;

ANIMALS; CAROTID ARTERIES; INTRACELLULAR FLUID; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RABBITS; SIGNAL TRANSDUCTION;

EID: 84929145053     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.01.079     Document Type: Article

References (61)

1. A.J. Ludman, D.M. Yellon, D.J. Hausenloy, Cardiac preconditioning for ischemia: lost in translation, Dis. Model. Mech. 3 (2010) 35-38.
2. M.R. Schmidt, M. Smerup, I.E. Konstaninov, M. Shimizu, J. Li, M. Cheung, et al., Intermittent peripheral tißue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic preconditioning, Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1883-H1890.
3. H.E. Botker, R. Kharbanda, M.R. Schmidt, M. Bøttcher, A.K. Kaltoft, C.J. Terkelsen, et al., Remote ischemic conditioning before hospital admißion, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomized trial, Lancet 375 (2010) 727-734.
4. G. Heusch, Cardioprotection: chances and challenges of its translation to the clinic, Lancet 381 (2013) 166-175.
5. L. Li, W. Luo, L. Huang, W. Zghang, Y. Gao, H. Jiang, et al., Remote preconditioning reduces myocardial injury in adult valve replacement: A randomized controlled trial, J. Surg. Res. 164 (2010) e21-e25.
6. D.M. Hong, E.-H. Lee, H.J. Kim, J.J. Min, J.-H. Chin, D.-K. Choi, et al., Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote ischaemic preconditioning with postconditioning outcome trial, Eur. Heart J. 35 (2014) 176-183.
7. F. Carrasco-Chinchilla, A.J. Muñoz-García, A. Domínguez-Franco, G. Millán-Vázquez, A. Guerrero-Molina, C. Ortiz-García, et al., Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial, Heart 99 (2013) 1431-1437.
8. J. Vinten-Johansen, W. Shi, Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption and future directions, J. Cardiovasc. Pharmacol. Exp. Ther. 16 (2011) 260-266.
9. G. Gritsopoulos, E.K. Iliodromitis, A. Zoga, D. Farmakis, E. Demerouti, A. Papalois, et al., Remote postconditioning is more potent than claßic postconditioning in reducing the infarct size in anesthetized rabbits, Cardiovasc. Drugs Ther. 23 (2009) 193-198.
10. G. Heusch, K. Boengler, R. Schulz, Cardioprotection: nitric oxide, protein kinases, and mitochondria, Circulation 118 (2008) 1915-1919.
11. G. Heusch, R. Schulz, Remote preconditioning, J. Mol. Cell. Cardiol. 34 (2002) 1279-1281.
12. S.Y. Lim, D.M. Yellon, D.J. Hausenloy, The neural and humoral pathways in remote limb ischemic preconditioning, Basic Res. Cardiol. 105 (2010) 651-655.
13. D.J. Hausenloy, A. Tsang, D.M. Yellon, The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning, Trends Cardiovasc. Med. 15 (2005) 69-75.
14. A. Tsang, D.J. Hausenloy, M.M. Mocanu, D.M. Yellon, Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway, Circ. Res. 95 (2004) 230-232.
15. A. Skyschally, P. vanCaster, K. Boengler, P.Gres, J.Musiolik, D. Schilawa, et al., Ischemic postconditioning in pigs: no causal role for risk activation, Circ. Res. 104 (2009) 15-18.
16. K. Boengler, A. Buechert, Ym Heinen, C. Roeskes, D. Hilfiker-Kleiner, G. Heusch, R. Schulz, Cardioprotection by ischemic postconditioning is lost in aged and STAT-3 deficient mice, Circ. Res. 102 (2008) 131-135.
17. G. Heusch, J. Musiolik, N. Gedik, A. Skyschally, Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigswith regionalmyocardial ischemia/reperfusion, Circ. Res. 109 (2011) 1302-1308.
18. K. Boengler, D. Hilfiker-Kleiner, G. Heusch, R. Schulz, Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion, Basic Res. Cardiol. 105 (2010) 775-785.
19. G. Heusch, J.Musiolik, E. Kottenberg, J. Peters, H. Jakob, M. Thielmann, STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication, Circ. Res. 110 (2012) 111-115.
20. E. Iliodromitis, I. Andreadou, E. Prokovas, A. Zoga, D. Farmakis, T. Fotopoulou, et al., Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: Poßible role of oxidative/nitrosative streß attenuation, Basic Res. Cardiol. 105 (2010) 193-203.
21. S. Philipp, X.-M. Yang, L. Cui, A.M. Davis, J.M. Downey, M.V. Cohen, Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade, Cardiovasc. Res. 70 (2006) 308-314.
22. D.J. Hausenloy, E.K. Iliodromitis, I. Andreadou, A. Papalois, G. Gritsopoulos, M. Anastasiou-Nana, et al., Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart, Cardiovasc. Drugs Ther. 26 (2012) 87-93.
23. P.C. Chiari, M.W. Bienengraeber, P.S. Pagel, J.G. Krolikowski, D.C. Kersten Warltier, Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: Evidence for anesthetic induced postconditioning in rabbits, Anesthesiology 102 (2005) 102-109.
24. L.M. Ludwig, D. Weihrauch, J.R. Kersten, P.S. Pagel, D.C. Warltier, Protein kinase C translocation and Src protein tyrosine kinase activation mediate isofluraneinduced preconditioning in vivo: Potential downstream targets of mitochondrial adenosine triphosphate-sensitive potaßium channels and reactive oxygen species, Anesthesiology 100 (2004) 532-539.
25. T. Makino, Y. Hattori, N. Matsuda, H. Onozuka, I. Sakuma, A. Kitabatake, Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial infarction in rabbits: reversal of altered expreßion of beta-adrenoceptor kinase and Gi alpha, J. Pharmacol. Exp. Ther. 304 (2003) 370-379.
26. I. Andreadou, D. Farmakis, E. Prokovas, F. Sigala, A. Zoga, K. Spyridaki, A. Papalois, A. Papapetropoulos, M. Anastasiou-Nana, D.T. Kremastinos, E.K. Iliodromitis, Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: Effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative streß, Cardiovasc. Res. 94 (2012) 501-509.
27. A. Sampatha, A. Raghupathi Reddya, B. Yakambarama, A. Thirupathia, M. Prabhakara, P. Reddy, V.P. Reddy, Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist, J. Pharm. Biomed. Anal. 50 (2009) 405-412.
28. S.-I. Bibli, I. Andreadou, E. Lazaris, A. Zoga, V. Varnavas, C.C. Andreou, et al., Myocardial protection provided by chronic skeletal muscle ischemia is not further enhanced by ischemic pre- or post-conditioning: comparative effects on intracellular signalling, J. Cardiovasc. Pharmacol. Ther. 19 (2014) 220-227.
29. I. Andreadou, E. Iliodromitis, E. Mikros, E. Bofilis, A. Zoga, M. Constantinou, et al., Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative streß, Free Radic. Biol. Med. 37 (2004) 500-510.
30. G. Schulte, H. Sommerschild, J. Yang, S. Tokuno, M. Goiny, C. Lövdahl, et al., Adenosine A receptors are neceßary for protection of themurine heart by remote, delayed adaptation to ischaemia, Acta Physiol. Scand. 182 (2004) 133-143.
31. W.A. Mutch, M.R. Graham, W.C. Halliday, J.M. Teskey, I.R. Thomson, Paraplegia following thoracic aortic croß-clamping in dogs. No difference in neurological outcome with a barbiturate versus isoflurane, Stroke 24 (1993) 1554-1559.
32. P. Xin, W. Zhu, J. Li, S. Ma, L. Wang, M. Liu, et al., Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning, Am. J. Physiol. Heart Circ. Physiol. 298 (2010) H819-H831.
33. S. Tamareille, V.Mateus, N. Ghaboura, J. Jeanneteau, A. Croue, D. Henrion, et al., RISK and SAFE signaling pathway interactions in remote limp ischemic preconditioning in combination with local ischemic postconditioning, Basic Res. Cardiol. 106 (2011) 1329-1339.
34. C. Penna, D. Mancardi, S. Raimondo, S. Geuna, P. Pagliaro, The paradigm of postconditioning to protect the heart, J. Cell. Mol. Med. 12 (2008) 435-458.
35. M.D. Goodman, S.E. Kosch, G.A. Fuller-Bicer, K.L. Butler, Regulating RISK: A role for JAK-STAT signaling in postconditioning? Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H1649-H1656.
36. R.F. Kelly, K.T. Lamont, S. Somers, D. Hacking, L. Lacerda, P. Thomas, et al., Ethanolamine is a novel STAT-3 dependent cardioprotective agent, Basic Res. Cardiol. 105 (2010) 763-770.
37. C.P. Lim, X. Cao, Regulation of Stat3 activation by MEK kinase 1, J. Biol. Chem. 276 (2001) 21004-21011.
38. G. Yamaura, T. Turoczi, F. Yamamoto, M.A.Q. Siddqui, N. Maulik, D.K. Das, STAT signaling in ischemic heart: A role of STAT5A in ischemic preconditioning, Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H476-H482.
39. J.H. Hanke, J.P. Gardner, R.L. Dow, P.S. Changelian, W.H. Brißette, E.J.Weringer, et al., Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor, J. Biol. Chem. 271 (1996) 695-701.
40. T. Miki, T. Miura, A. Tsuchida, A. Nakano, T. Hasegawa, T. Fukuma, K. Shimamoto, Cardioprotectivemechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation, Circulation 102 (2000) 458-463.
41. M. Sato, R.M. Engelman, H. Otani, N.Maulik, J.A. Rousou, J.E. Flack III, et al., Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: Implication of bradykinin-dependent and bradykininindependent mechanisms, Circulation 102 (Suppl. 3) (2000) 346-351.
42. T. Omura, M. Yoshiyama, F. Ishikura, H. Kobayashi, K. Takeuchi, S. Beppu, J. Yoshikawa, Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivomyocardiumof rats, J.Mol. Cell. Cardiol. 33 (2001) 307-316.
43. T. Raßaf, M. Totzeck, U.B. Hendgen-Cotta, S. Shiva, G. Heusch, M. Kelm, Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning, Circ. Res. 114 (2014) 1601-1610.
44. P.F.Mount, B.E. Kemp, D.A. Power, Regulation of endothelial andmyocardial NO synthesis by multi-site eNOS phosphorylation, J. Mol. Cell. Cardiol. 42 (2007) 271-279.
45. C. Communal, M. Sumandea, P. de Tombe, J. Narula, R.J. Solaro, R.J. Hajjar, Functional consequences of caspase activation in cardiac myocytes, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6252-6256.
46. U. Weiland, J. Haendeler, C. Ihling, U. Albus, W. Scholz, H. Ruetten, A.M. Zeiher, S. Dimmeler, Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion- induced myocardial apoptosis via a caspase-3 dependent pathway, Cardiovasc. Res. 45 (2000) 671-678.
47. M.J. Kohr, J. Sun, A. Aponte, G.Wang, M. Gucek, E.Murphy, C. Steenbergen, Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-aßisted capture, Circ. Res. 108 (2011) 418-426.
48. C.P. Baines, M. Goto, J.M. Downey, Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium, J. Mol. Cell. Cardiol. 29 (1997) 207-216.
49. C. Penna, R. Rastaldo, D. Mancardi, D. Raimondo, S. Cappello, D. Gattullo, et al., Postconditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K channel and protein kinase C activation, Basic Res. Cardiol. 101 (2006) 180-189.
50. Z. Mansour, A.L. Charles, J. Bouitbir, J. Pottecher, M. Kindo, J.-P. Mazzucotelli, et al., Remote and local ischemic postconditioning further impaired skeletal muscle mitochondrial function after ischemia-reperfusion, J. Vasc. Surg. 56 (2012) 774-782.
51. L.M. Yung, W.T.Wong, X.Y. Tian, F.P. Leung, L.H. Yung, Z.Y. Chen, et al., Inhibition of renin angiotensin system reverses endothelial dysfunction and oxidative streß in estrogen deficient rats, PLoS ONE 6 (2011) e17437.
52. W. Warsch, E. Grundschober, A. Berger, L. Gille, S. Cerny-Reiterer, A.S. Tigan, et al., STAT5 triggers BCR-ABL1mutation bymediating ROS production in chronicmyeloid leukaemia, Oncotarget 3 (2012) 1669-1687.
53. P.N. Seshiah, D.S.Weber, P. Rocic, L. Valppu, Y. Taniyama, K.K. Griendling, Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators, Circ. Res. 91 (2002) 406-413.
54. N. Wu, H. Yu, X.H. Zhu, H.J. Yuan, Y. Kang, J.J. Jiao, W.Z. Gao, Y.X. Liu, J.S. Lou, Noninvasive delayed limb ischemic preconditioning attenuates myocardial ischemia-reperfusion injury in rats by a mitochondrial K(ATP) channel-dependent mechanism, Physiol. Res. 60 (2011) 271-279.
55. J.P. French, K.L. Hamilton, J.C. Quindry, Y. Lee, P.A. Upchurch, S.K. Powers, Exerciseinduced protection against myocardial apoptosis and necrosis: MnSOD, calciumhandling proteins, and calpain, FASEB J. 22 (2008) 2862-2871.
56. N. Vesentini, C. Barsanti, A. Martino, C. Kusmic, A. Ripoli, A. Roßi, A. L'Abbate, Selection of reference genes in different myocardial regions of an in vivo ischemia/reperfusion rat model for normalization of antioxidant gene expreßion, BMC Res. Notes 5 (2012) 124.
57. S. De Zeeuw, T.W. Lameris, D.J. Duncker, D. Hasan, F. Boosma, A.H. van der Meiracker, P.D. Verdouw, Cardioprotection in pigs by exogenous norepinephrine but not by cerebral ischemia-induced release of endogenous norepinephrine, Stroke 32 (2001) 767-774.
58. S. Tokuno, K. Hinokiyama, K. Tokuno, C. Löwbeer, L.O. Hanßon, G. Valen, Spontaneous ischemic events in the brain and heart adapt the hearts of severely atherosclerotic mice to ischemia, Arterioscler. Thromb. Vasc. Biol. 1 (2002) 995-1001.
59. G. Crimi, S. Pica, C. Raineri, E. Bramucci, G.M. De Ferrari, S. Pica, B. Marinoni, A. Repetto, A. Raisaro, S. Leonardi, P. Rubartelli, L.O. Visconti, M. Ferrario, Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anteriormyocardial infarction. A randomized controlled trial, JACC Cardiovasc. Interv. 6 (2013) 1055-1063.
60. K.W. Eriksen, K. Kaltoft, G.Mikkelsen, M. Nielsen, Q. Zhang, C. Geisler, M.H. Nißen, C. Röpke, M.A. Wasik, N. Odum, Constitutive STAT3-activation in Sezary syndrome: Tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expreßion and growth of leukemic Sezary cells, Leukemia 15 (2001) 787-793.
61. V.S. Polikov, J.-S. Hong, W.M. Reichert, Soluble factor effects on glial cell reactivity at the surface of gel-coated microwires, J. Neurosci. Methods 190 (2010) 180-187.